Company Nascent Biotech, Inc. Other OTC
Equities
NBIO
US63108Q1013
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sean Carrick
CEO | Chief Executive Officer | 56 | 14/07/14 |
Lowell Holden
DFI | Director of Finance/CFO | 82 | 14/07/14 |
Douglas Karas
BRD | Director/Board Member | 59 | 03/04/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lowell Holden
DFI | Director of Finance/CFO | 82 | 14/07/14 |
Sean Carrick
CEO | Chief Executive Officer | 56 | 14/07/14 |
Douglas Karas
BRD | Director/Board Member | 59 | 03/04/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 169,729,565 | 101,841,640 ( 60.00 %) | 0 | 60.00 % |
Company contact information
Nascent Biotech, Inc.
623 US Highway 1 Suite 407
33408, North Palm Beach
+
http://www.nascentbiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.45% | 26.64B | |
-21.81% | 19.91B | |
-16.75% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |